ESP Block in MIS Lumbar Spine Surgery
Recruiting
N/A
Interventional Study
Patients With Spinal Stenosis Indicated for MIS TLIF
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 48 (estimated)
- Sponsor
- Hospital for Special Surgery, New York · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective, randomized controlled trial of patients undergoing minimally invasive transforaminal lumbar interbody fusion. This study will randomize patients into one of two groups: erector spinae plane (ESP) block and no ESP block.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18-80
* Patients scheduled for MIS TLIF (any level) with the principal investigator
* ASA 1, 2, 3
Exclusion Criteria:
* ASA 4 or higher
* BMI \>40
* Chronic opioid use (daily use for \> 3 months)
* Revision surgery, any history of previous lumbar spine surgery
* Allergy …
Contacts